Abstract

Introduction: The in vitro maturation (IVM) of oocytes is an essential step in the in vitro embryo production. This study aimed to improve the efficacy of IVM by supplementing with granulocytemacrophage colony stimulating factor (GM-CSF) in the culture medium.


Methods: The combinatorial effects of GM-CSF and porcine follicular fluid (pFF) were also investigated in porcine cumulusoocyte complex (COC) models. COCs were obtained by aspirating follicles with an 18 G needles. Small and medium follicles were used in this study. COCs from two kinds of follicles were divided into 13 groups to investigate the maturation of COCs at different concentrations of pFF (0, 10%) and GM-CSF (0, 2, 10, 20 ng/mL). The maturation of COCs was evaluated by different variables including cumulus expansion, the appearance of the first polar body, lipid droplet localization, mitochondrial distribution, and cortical granule distribution.


Results: The results showed that GM-CSF improves the cumulus expansion, and stimulate the mitochondrial and cortical granule movement. However, GM-CSF did not increase nuclear maturation or lipid droplet localization rates in the porcine oocyte.


Conclusion: In conclusion, porcine GM-CSF had some positive effects on the porcine oocyte maturation.


 


Introduction

In vitro maturation (IVM) is an assisted reproductive technology for women. It is usually indicated for cases with problems in oocyte maturation such as Polycystic Ovary Syndrome (PCOS). The advantages of IVM include low cost, short time, and especially limiting harmfulness to patients by using just small doses of steroid hormones. Thus, IVM can be used as an alternative for superovulation technique in the conventional in vitro fertilization procedures. However, the quality of oocytes after IVM is variable, leading to low rates of embryonic development when compared to that of oocytes matured in vivo 1.

Oocyte maturation is enhanced by the addition of follicular fluid (FF) to media by increasing the rate of successful maturation, monospermic fertilization, and promote male pronucleus formation 2. The effects of FF can be further enhanced by the combination of growth factors, amino acids, hormones, cytokines, etc. 3,4,5. However, the composition of FF is complex, and the roles and concentration of many substances in FF are unknown. Although FF is commonly added to porcine IVM medium, its quality varies from ovary to ovary and depends on the size of the follicles.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is known as colony-stimulating factor 2 in the CSF family. When it was first discovered in the 1960s, colony-stimulating factor (CSF) was the general name for cytokines responsible for promoting the proliferation of bone marrow cells in culture. By the early 1970s, the scientists had established that there were four CSFs: Granulocyte colony-stimulating factor (G-CSF), Macrophage colony-stimulating factor (M-CSF), Granulocyte-macrophage colony-stimulating factor (GM-CSF), and multi-CSF. GM-CSF was the first of the CSFs to be described chemically.

GM-CSF is a glycoprotein with structure and molecular weight different from species to species. In myeloid cells, GM-CSF binds to a specific receptor on the cell membrane with a high affinity. The receptor is composed of two subunits, α and β: the α-subunit is unique to GM-CSF but has low affinity; the β-subunit is shared by the interleukin (IL)-5 and interleukin-3 (IL-3) receptors 6. When combining into the receptor complex, they convert the low-affinity interaction to a high affinity interaction 7,8. By binding to its receptor, GM-CSF induces changes in gene expression through the Janus kinase/signal transducers and activators of transcription (JAK/STAT), Ras/Raf/mitogen-activated protein kinase, mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3-K) pathways 6.

In 1977, GM-CSF was purified from mouse lung for the first time 9. At first, GM-CSF was believed to only stimulate the generation of both macrophage and granulocyte colonies from hematopoietic precursor cells 10. However, with new evidence, GM-CSF is known to have effects on various cell types and organs such as liver 11, kidney 12, brain 13 etc. After almost forty years, the biological aspect of GM-CSF has been well-studied. GM-CSF can be produced by many cell types such as activated T-cell, B-lymphocytes, endothelial cells, keratinocytes, fibroblasts, and evenly tumor cells 14,15. GM-CSF synthesis is regulated by a variety of factors such as prostaglandin, toll-like receptor (TLR) agonists, TNF- α, interleukin-1, T-cell receptor, and co-receptor stimulation 16,17,18. In addition to being found in hematopoietic cells, the GM-CSF receptor is also present on the membrane of microglia, endothelial cells, mesenchymal cells, and tumor-derived cells 19. Studies have shown that the regulatory functions of GM-CSF are important in cell proliferation, cell differentiation, cell activation, apoptosis inhibition 20, and maybe more.

While studying female gonad, GM-CSF and its receptor were found in uterus, oviducts, ovaries, and follicles 8. The presence of GM-CSF in these organs suggested the importance of GM-CSF in the reproduction. In a study investigating the physiological role of GM-CSF in ovaries, mice that lost the GM-CSF gene had a longer estrous cycle by 1.5 days, a lower number of cells in the ovaries, and a slow progesterone synthesis during pregnancy 21. In addition, progesterone and estrogen concentration control the GM-CSF synthesis, which suggests that GM-CSF may have a regulating function during estrous cycles in mammals. Thus, the expression of GM-CSF in the ovary and uterus, coupled with its regulatory function as a steroid, further indicates the functions of GM-CSF in the normal physiology of the reproductive system.

In the follicles, the expression level of GM-CSF receptor in theca, granulosa, and luteal cells coincides with the stage of follicular development, ovulation, and luteal phase formation. The murine cumulus-oocyte complexes (COCs) express mRNA for the α-subunit of the GM-CSF receptor, which facilitates the uptake of glucose, and enhances the viability of oocytes 22,8. GM-CSF receptor is also present on the membrane of immature oocytes, fertilized oocytes, and embryo at the blastocyst stage in both humans and mice 23. In addition, the previous studies showed that GM-CSF was found in the FF with a lower concentration than in the serum 24,25. As such, GM-CSF may have important roles in the development and maturation of oocytes.

In this study, we investigated the effects of GM-CSF individually as well as combinedly with the porcine follicular fluid (pFF) on the IVM of the cumulus-oocyte complex.

Methods

Porcine ovary collection

At local slaughterhouses, the porcine ovaries were collected immediately when the female gonads were exposed. Pink ovaries with even follicles containing clear fluid were chosen. Then, the ovaries were washed with warm saline solution supplemented with 100 IU/mL penicillin and 0.1 mg/mL streptomycin sulfate to remove blood and contaminants. The ovaries were stored in the saline solution with antibiotic supplements at 32-38oC and transfer to the laboratory within one hour.

Porcine follicular fluid preparation

The porcine follicular fluid (pFF) was prepared as the published study 2. Briefly, pFF was extracted from 3 to 7 mm follicles of porcine ovaries. After centrifugation for 30 min at 13,000 rpm at 4oC, the supernatants were collected and filtered through 0.45 mm filters (Gelman Sciences, Ann Arbor, MI). The pFF was stored at -20°C immediately until used 2.

Cumulus-oocyte complex (COCs) collection

COCs were collected by aspirating small follicles (SF) (1-3 mm) and medium follicles (MF) (3-7 mm). The COCs were aspirated using an 18-G needle attached to a 10 ml disposable syringe with modified D-PBS (Dulbecco’s PBS supplemented with 3.5% bovine serum albumin, 1 g/L D-glucose and 36 mg/L sodium pyruvate, 100 IU/mL penicillin and 0.1 mg/mL streptomycin sulfate).

In vitro maturation

Only compacted COCs with more than three uniform layers of cumulus cells and homogenous cytoplasm were rinsed twice with in vitro maturation medium (IVMM) and incubated at 38.5 °C in a humidified atmosphere of 5% CO2. The IVMM was M199 (Gibco, Thermo Fisher Scientific, MA) supplemented with 0.1% polyvinyl alcohol (PVA), 0.57 mM L-cysteine, 0.91 mM sodium pyruvate, 3.05 mM D-glucose, 10 ng/mL epidermal growth factor (EGF), 10 IU/mL pregnant mare serum gonadotropin (PMSG), 10 IU/mL human chorionic gonadotropin (hCG), 50 IU/mL penicillin and 50 mg/mL streptomycin sulfate 26.

To evaluate the pFF and GM-CSF effects on the maturation of COCs, COCs were cultured in various conditions that IVMM supplemented with or without 10% pFF in combination with different concentrations of GM-CSF. COCs were divided into two groups based on the diameter of follicles: small follicles and medium follicles. These COCs were divided into the following 13 groups with different culture medium and diameter of follicles with at least 30 COCs per sub-groups:

SF-G0: COCs from small follicles were cultured in IVMM without pFF or GM-CSF supplement

SF-G2: COCs from small follicles were cultured in IVMM with 2 ng/mL GM-CSF, without pFF

SF-G10: COCs from small follicles were cultured in IVMM with 10 ng/mL GM-CSF, without pFF

SF-P0: COCs from small follicles were cultured in IVMM with 10% pFF, without GM-CSF

SF-P2: COCs from small follicles were cultured in IVMM with 10% pFF and 2 ng/mL GM-CSF

SF-P10: COCs from small follicles were cultured in IVMM with 10% pFF and 10 ng/mL GM-CSF

MF-G0: COCs from medium follicles were cultured in IVMM without pFF or GM-CSF supplement

MF-G2: COCs from medium follicles were cultured in IVMM with 2 ng/mL GM-CSF, without pFF

MF-G10: COCs from medium follicles were cultured in IVMM with 10 ng/mL GM-CSF, without pFF

MF-P0: COCs from medium follicles respectively were cultured in IVMM with 10% pFF, without GM-CSF

MF-P2: COCs from medium follicles were cultured in IVMM with 10% pFF and 2 ng/mL GM-CSF

MF-P10: COCs from medium follicles were cultured in IVMM with 10% pFF and 10 ng/mL GM-CSF

MF-P20: COCs from medium follicles were cultured in IVMM with 10% pFF and 20 ng/mL GM-CSF

Assessment of cumulus expansion

At 0 and 20th hour in IVM, COCs were micro-photographed, and the diameter of each COC was measured with AxioVision Microscope Software (Carl Zeiss, Germany).

Assessment of the first polar body

After incubating for 40-44 hours, COC-culturing medium was added with hyaluronidase enzyme till achieving concentration at 80 IU/mL and aspirated for 1-2 minutes or until the oocytes were denuded almost completely. Then, the oocytes were quickly rinsed in pre-warmed IVMM two times to remove the enzyme. Finally, each group of 10-15 oocytes was allocated into 50-mL drops of pre-warmed IVMM overlaid with mineral oil. Each oocyte was rotated with microinjection pipette using a micromanipulation system (Eppendorf, Germany) to visualize the first polar body 27.

To assess the agency of IVM, oocytes were classified based on the first polar body morphology according to the method of Lin T. et al. with some modifications 28. “Class A” oocytes were defined as round or ovoid polar body with an intact membrane (smooth surface or not). Otherwise, “Class B” oocytes were defined with a broken or fragmented polar body, and were considered as poor quality (Figure 1).

Figure 1 . The porcine oocytes with first polar body after IVM . (Left) Class A oocyte with the round or ovoid polar body. (Right) Class B oocyte with broken or fragmented polar body

Assessment of lipid droplet localization

The oocytes were evaluated by the method of Hiraga K. et al. (2013) with some modifications 29. Briefly, with the micromanipulation system, the denuded oocytes were observed with an inverted microscope and classified into two groups according to the localization patterns of lipid droplets. “Class I” group included oocytes with the lipid droplets distributed centrally and had a light ring between membrane and lipid droplets. “Class II” group included oocytes with the lipid droplets located uniformly throughout the entire cytoplasm (Figure 2).

Figure 2 . The localization patterns of lipid droplets in porcine oocytes after IVM . ( A ) Class I oocyte with the lipid droplets distributed centrally and a light ring outside. ( B ) Class II oocyte with the lipid droplets located uniformly throughout the entire cytoplasm.

Assessment of mitochondrial distribution

After denuding, the oocytes were transferred into pre-warmed IVMM supplemented with 0.5 mM MitoTracker Red CMXRos (Invitrogen, USA) and incubated for 30 minutes at 38.5°C in 5% CO2. Then, oocytes were rinsed twice in IVMM for 15 minutes each and fixed in 4% paraformaldehyde in PBS for 30 min at 38.5°C in 5% CO2. Finally, the oocytes were mounted between a glass slide and a coverslip. Scans and records were taken through the equatorial flat of the oocyte using a confocal laser scanning microscopy system (LSM 800, Carl Zeiss, Germany) with 39 μm pinhole.

The mitochondrial distribution includes three patterns 30:

- Type P: the peripheral pattern showed mitochondria distributed in proximity to oolema

- Type S: the semiperipheral pattern showed mitochondria covering the outer part of the cytoplasmic volume heterogeneously or/and in proximity to oolema

- Type M: the diffuse pattern showed mitochondria distributed homogeneously throughout the ooplasm.

Oocytes with the diffuse pattern were classified as mature and those with peripheral and semiperipheral mitochondrial distributions were classified as immature (Figure 3).

Figure 3 . The mitochondrial distribution in porcine oocytes after IVM . ( A ) Type P oocyte with the peripheral pattern: mitochondria distributed near oolema. ( B ) Type S oocyte with the semiperipheral pattern: mitochondria distributed in the outer part of the cytoplasmic volume heterogeneously and near oolema. ( C ) Type M oocyte with the diffuse pattern: mitochondria distributed homogeneously throughout the ooplasm.

Assessment of the cortical granule distribution

The denuded oocytes were fixed with 4% paraformaldehyde in PBS for 30 minutes at room temperature. Then, oocytes were permeabilized with 0.1% Triton X-100 in PBS for 10 minutes and rinsed with blocking solution (PBS containing 0.3% BSA and 100 mM glycine) for 10 minutes. Next, the oocytes were stained with 10 mg/mL fluorescein isothiocyanate-labeled peanut agglutinin in PBS for 30 minutes in the dark at room temperature. After staining, the oocytes were rinsed twice in PBS for 10 minutes each. Finally, the oocytes were mounted on a slide, and then scanned and recorded as described previously 31.

The cortical granule distribution is divided into three patterns:

Type W: fluorescent signals were distributed in the whole oocyte cytoplasm

Type C: fluorescent signals covering the cortex and in proximity to oolema

Type M: the CGs were closely located beneath the membrane and formed a brilliant continuous ring (Figure 4).

The oocytes with CG fluorescent signals beneath the membrane were classified as mature and those with the other types of cortical granule distribution as immature.

Figure 4 . The cortical granule distribution in porcine oocytes after IVM . ( A ) Type W oocyte: The cortical granules distributed in the whole oocyte cytoplasm. ( B ) Type C oocyte: The cortical granules covered the cortex and in close to oolema; Type M oocyte: The cortical granules were closely located beneath the membrane and formed a brilliant continuous ring. Green: FITC- labeled peanut agglutinin. Blue: Hoechst 33342.

Statistical analysis

At least 30 COCs in each group were analyzed. The data was carried out using analysis of variance (ANOVA) for cumulus expansion assessment and Chi-square test for ratio comparisons. The P-value was calculated by using GraphPad Prism 6.0 software. Unless otherwise indicated, differences of P < 0.05 were considered significant.

Results

GM-CSF stimulated the cumulus expansion during IVM of COCs from medium follicles

In this experiment, COCs from medium follicles were used to evaluate the effects of GM-CSF and pFF on IVM. The results represented in the Figure 5 showed that after 20 hours of culture in some different conditions (MF-G0, MF-G2, MF-G10, MF-P0, MF-P2, MF-P10, MF-P20), the cumulus expansion was different between these groups.

Compared to before culturing, the COCs of MF-G2, MF-G10, MF-P0, MF-P2, MF-P10 and MF-P20 significantly increased their cumulus layer (p<0.05). However, this observation was not observed in MF-G0 (without supplements of pFF or GM-CSF).

The results also showed that the cumulus expansion of COCs in groups MF-G10 (only supplemented with GM-CSF) and MF-P0 (only supplemented with pFF) were similar (p>0.05), and significantly different from the group MF-G0 (p<0.01) ( 238.7 ± 52.8, 243.7 ± 41.7 and 200.3 ± 34.0, respectively). While in the groups MF-P2, MF-P10, and MF-P20 that supplemented both pFF and GM-CSF (304.8 ± 85.1, 301.6 ± 89.6 and 307.2 ± 98.3, respectively), the cumulus expansion was stronger than in MF-P0 that only supplemented pFF (Figure 5).

Figure 5 . The diameters of COCs from medium follicles before and after 20 hours of IVM . Time 0 (before culture) revealed the average diameter of COCs in all groups at the culture starting time. The graph did not express a significant difference between the average diameter of COCs of individual groups (except for no supplemented GM-CSF group) and that at time 0 (P < 0.05). # significant difference with P < 0.05; ## and ** significant difference with P < 0.01; *** significant difference with P < 0.0001

GM-CSF did not improve the appearance and morphology of the first polar body of both oocytes from small follicles and medium follicles

The supplement of pFF in IVMM of SF-P0 and MF-P0 group slightly increased the percentage of matured oocytes with the first polar body extrusion compared to SF-G0 and MF-G0 group (without supplements of pFF or GM-CSF), respectively, but this increase was non-significant.

In the MFs, when assessing only GM-CSF supplemented groups, the polar body extrusion rate in MF-G10 group (64.1%) was significantly lower (P <0.05) than in MF-G0 group (75%). Similarly, the percentage of oocytes with the first polar body appeared in the pFF and GM-CSF supplemented groups reduced after cultured in IVMM. This rate in MF-P0 decreased significantly from 84% to 72,5% in MF-P10 (P <0.05) and 65,2% in MF-P20 group (P <0.001).

However, the effects of pFF and GM-CSF on the appearance of the first polar body in oocytes from SFs were different to from MFs. The supplements of GM-CSF at 2 ng/mL (group SF-P2) and 10 ng/mL (group SF-P10) to pFF-supplemented IVMM slightly increased the percentage of oocytes appearing the first polar body. The oocytes’ polar body extrusion in only GM-CSF-supplemented groups (SF-G2 and SF-G10) also slightly increased compared to without GM-CSF group (SF-G0). Although, these increases were not strong enough to be significant (Figure 6). Results of the first polar body morphological assessment showed that non-significant difference was detected in all groups of COCs from either MFs or SFs.

Figure 6 . Effects of pFF and GM-CSF on the appearance of the first polar body in oocytes collected from (A) medium and (B) small follicles after IVM . */** significant difference with p<0.05 and p<0.001, respectively.

GM-CSF did not improve the lipid droplets distribution of both oocytes from SFs and MFs

The effects of pFF and GM-CSF on lipid droplet distribution of oocytes from small and medium follicles were presented in Figure 7. For the MFs, results showed that pFF significantly increased the re-arrangement and distribution of lipid droplets inside the oocytes in MF-P0 compared to MF-G0 (p<0.05) (60.6% and 35.3%, respectively). The supplement of GM-CSF in MF-G2 (2ng/mL GM-CSF) and MF-G10 (10 ng/mL GM-CSF) gently increased the percentage of class I oocytes compared to MF-G0 without pFF and GM-CSF, though these differences were non-significant. However, in the presence of pFF (MF-P2 and MF-P10), GM-CSF reversed effects of pFF to lipid droplet distribution. Indeed, the percentage of oocytes with good lipid droplet re-arrangement significantly decreased (60.6% in MF-P0, 31.7% in MF-P2 and 16.7% in MF-P10) (p<0.05) (Figure 7A).

For oocytes from SFs, the supplement of pFF in the IVMM did not affect the lipid droplet re-arrangement. The slight increase of class I oocytes was recorded in SF-G2 compared to SF-G0, but it was not significant. Similar to oocytes from medium follicles, in the presence of pFF, GM-CSF caused a strong reduction of oocytes with good lipid droplet distribution, especially at the high concentration of GM-CSF (10 ng/mL). The percentage of class I oocytes was 12.5% in MF-P10, which is significantly lower than 33.33% in MF-P0 and 31.33% in MF-P2 (p<0.05) (Figure 7B).

Figure 7 . Effects of pFF and GM-CSF on the lipid droplet distribution in oocytes collected from (A) medium and (B) small follicles after IVM. Bars with different letters are significantly different (p < 0.05).

GM-CSF promoted the mitochondrial movement in oocytes from SFs and MFs

The useful effects of pFF and GM-CSF on the mitochondrial distribution of oocytes from medium follicles were demonstrated in Figure 8. The supplement of GM-CSF significantly increased the percentage of M-type oocytes from 22.85% in MF-G0 to 46.88% in MF-G10 (p<0.05). The similar result was detected at the comparison between MF-P0 and MF-G0 (48.5% in MF-P0) (p<0.05). We also recorded that the percentage of M-type oocytes in MF-G10 was not different to in MF-P0, which meant that pFF at 10% and GM-CSF 10 ng/ml in standard IVMM would have the same effects on the mitochondrial distribution in medium follicles-derived oocytes.

Figure 8 . Effects of pFF and GM-CSF on the mitochondrial distribution in oocytes collected from medium follicles after IVM . */**/*** significant difference with p<0.05, p<0.01 and p<0.0001, respectively.

In the presence of pFF, the percentage of S-type oocytes strongly decreased from 42.42% in MF-P0 to 14.63% in MF-P2 (p<0.01); the percentage of M-type oocytes increased from 48.5% in MF-P0 to 70.7% in MF-P2, but this increase was not significant. Even though, when comparing MF-P2 to MF-G0, the percentage of S-type oocytes was much lower and the percentage of M-type oocytes was significantly higher (p<0.0001) (62.86% of S-type and 22.85% of M-type in MF-G0). However, when the GM-CSF concentration was up to 10 ng/mL, the percentage of S- and M-type oocytes in MF-P10 was similar to in MF-P0. In addition, when comparing the MF-P10 to MF-P2, the results showed a decrease (p <0.05) of M-type oocytes to 42.8% and an increase (p<0.05) of S-type oocytes up to 37.1% in MF-P10.

For assessment of SFs, the GM-CSF supplement significantly reduced the percentage of P-type oocytes from 26.5% in SF-G0 to 8.6% in SF-G2 (p<0.05). Similarly, this percentage in SF-P0 was 7.7%, significantly lower than in SF-G0 (p<0.05) and there was no difference between SF-G2 and SF-P0. In the groups of pFF and GM-CSF supplement, the only significant difference was the percentage of S-type oocytes decreased from 56,4% in SF-P0 to 34,1% in SF-P10 (p<0.05) (Figure 9).

Figure 9 . Effects of pFF and GM-CSF on the mitochondrial distribution in oocytes collected from small follicles after IVM . *significant difference with p<0.05

GM-CSF showed positive effects on the cortical granule distribution of oocytes from SFs and MFs

In medium follicle-derived COCs, after cultured, the percentage of three type oocytes were not significantly different between MF-G0 (without GM-CSF and pFF) vs. MF-P0 (only 10% pFF). This result suggested that pFF at 10% of IVMM could not affect the CG distribution. However, at the group of GM-CSF 2 ng/mL (MF-G2), the percentage of C-type oocytes significantly reduced from 42.86% in MF-G0 to 20% (p<0.05). In addition, the concentration of 2 ng/mL GM-CSF (MF-G2) could enhance the percentage of M-type oocytes up to 65%, significantly higher than 39.39% in MF-P0 (p<0.05). Moreover, when GM-CSF concentration increased to 10 ng/mL, the percentage of W-type oocytes in MF-G10 was 3.13%, significantly lower compared to 21.21% of MF-P0 (p<0.05). These results showed that GM-CSF was better than pFF in the CG distribution (Figure 10).

In the combination of GM-CSF and pFF, at low concentration of GM-CSF (2ng/mL) (group MF-P2), the percentage of W-type oocytes significantly decreased compared to MF-P0 (without GM-CSF) (p<0.05) (4.88% and 21.21%, respectively). Besides, at higher concentration of GM-CSF (10 ng/mL), the percentage of C-type oocytes reduced in MF-P10 compared to MF-P0 and MF-P2 (17.14% vs. 41.46% and 39.39% respectively for MF-P10, MF-P2, and MF-P0) (p<0.05); and the M-type oocytes significantly increased from 39.39% at MF-P0 to 65.71% at MF-P10 (p<0.05). Initially, in combination with pFF, GM-CSF could stimulate the movement of cortical granules from the cytoplasm to oolema.

Figure 10 . Effects of pFF and GM-CSF on the cortical granule distribution of in oocytes collected from medium follicles after IVM . * significant difference with p<0.05.

For the small follicle-derived COCs, the effects of GM-CSF and pFF were similar in the CG contribution (p>0.05). Reversely, in combination with pFF, GM-CSF at 2 ng/mL strongly decreased the percentage of W-type oocytes compared to the IVMM supplemented with only GM-CSF or pFF (9.76%, 33.33% and 29.41% for SF-P10, SF-P0, and SF-G0, respectively)(p<0.05). In addition, the percentage of M-type oocytes significantly increased to 65.85% at SF-P2 while compared to 25.64% at SF-P0 and 29.41% at SF-G0 (p<0.01). Thus, the GM-CSF and pFF combination stimulated the maturation of CGs (Figure 11).

When GM-CSF increased to 10 ng/mL (SF-P10), the percentage of W-type oocytes reduced to 9.76%, which is the same as SF-P2. However, the percentage of M-type oocytes significantly decreased to 36.59% at SF-P10 in comparison with 65.85% at SF-P2 (p<0.01); and the percentage of C-type increased from 24.39% at SF-P2 to 53.66% at SF-P10 (p<0.01). Both became similar to which at SF-P0 and SF-G0. This observation suggested that the high concentration of GM-CSF promoted the CG motility but inhibited the CG arrangement beneath the oolema.

Figure 11 . Effects of pFF and GM-CSF on the cortical granule distribution in oocytes collected from small follicles after IVM . */**/*** significant difference with p<0.05, p<0.01 and p<0.001, respectively.

Discussion

In this study, we evaluated the maturation of porcine oocytes under GM-CSF treatment. In a few studies about the effects of GM-CSF on oocyte maturation, our study was the first one to evaluate the effect of GM-CSF in combination with pFF. Previously, the effect of GM-CSF was assessed only in a synthetic medium by using 10% FBS in TCM 199 as the control 1.

In our experiment, GM-CSF has shown its effect on cumulus expansion. When comparing the average diameters of COCs at 20th hour in the only-GM-CSF supplemented group, a significant difference between MF-G10 and MF-G0 demonstrates that GM-CSF stimulates the expansion of cumulus cell layers, which is consistent with the results in the previous study 32. Additionally, the COC average diameter of MF-G10 group was similar to MF-P0, and both were significantly higher than MF-G0 revealing that GM-CSF had the same stimulation as pFF on cumulus cell dilatation. Moreover, the combination of pFF and GM-CSF induced strong expansion of the cumulus cells, and this effect was stronger than the addition of either pFF or GM-CSF.

According to Nagyova's study, cumulus expansion and hyaluronic acid synthesis in pigs did not depend on the secreted factor from oocytes 33, which suggested that GM-CSF had a direct effect on cumulus cells. In addition, Peralta's research showed that GM-CSF acted via the PI3K pathway 32, and previous studies also showed that EGF receptor-dependent cumulus expansion mechanisms were via the PI3K, AKT, and MAPK3/1 34,35. Thus, it is possible that the GM-CSF receptor may have a role in the cumulus expansion similar to the EGF receptor.

About the first polar body extrusion, our results showed that GM-CSF was harmful to the polar body extrusion rate in the group of oocytes from MFs and had no effect on the group of oocytes from SFs. However, in a previous study, GM-CSF was demonstrated not to affect the oocyte maturation rate when GM-CSF levels were increased from 1 to 100 ng/mL 32. These contradictory results may be due to Peralta assessed the impact of human GM-CSF on bovine oocytes, and our study evaluated the effect of porcine GM-CSF on porcine oocyte. This explanation is supported by the fact that GM-CSF structure is species specific 36. Genetic suitability may be the reason why porcine GM-CSF has a strong impact on porcine oocytes.

In the nuclear maturation research, EGF was found that it functioned similarly to FSH activity under in vitro conditions, which could completely replace natural FSH in stimulating the polar body formation 37. In addition, EGF-like factors also were shown to have similar effects, via the EGF receptor signaling pathways. However, FSH affected through a variety of signaling pathways, not just the EGF receptor 38. Thus, the nuclear maturation in oocytes was regulated by multiple pathways, and the GM-CSF receptor might be one of them.

With the results obtained, GM-CSF showed its detrimental effect on the polar body formation, even in the presence of FSH, LH (in PMSG, hCG, pFF), and EGF. However, the mechanism behind this process still requires more research to clarify and identify the relevant signaling pathways in oocytes.

At the 20 ng/mL concentration (MF-P20), GM-CSF showed a strong decrease in the polar body extrusion rate compared to groups of 2 ng/mL and no supplementation. Therefore, we did not use the 20 ng/mL GM-CSF supplemented IVMM in the next experiments.

GM-CSF did not improve the lipid droplet distribution of oocytes. Additionally, GM-CSF reversed the beneficial effects of pFF when combined in IVMM. In the method article, Hiraga used a non-supplemented TFF medium, or TCM with serum, similar to the only pFF supplemented group in this study 29. From 2013, there were no new studies have evaluated the distribution of lipid droplets after IVM. Therefore, the mechanism of lipid droplet migration has not been determined. It is hard to explain how pFF and GM-CSF affected the lipid droplet distribution. Our experiment was the first one to demonstrate the positive effects of pFF on the distribution of lipid droplets in oocytes after IVM.

In medium follicle-derived COCs, while single pFF or GM-CSF supplement enhanced the distribution of mitochondria throughout the ooplasm, the pFF and GM-CSF combination promoted the migration of mitochondria from the outer part to the whole oocyte. However, the high concentration of GM-CSF would negate these positive effects. On the other hand, GM-CSF did not affect COCs from SFs. The slight decreases in the percentage of P-type oocytes meant GM-CSF might stimulate the re-arrangement of mitochondria at the early stage. There was not enough proof for GM-CSF effects on the movements of mitochondria in the oocytes from SFs. In general, GM-CSF had positive effects on the mitochondrial distribution of oocytes, which was stronger when combined with pFF but the combined effect was inactivated at high concentrations.

The mitochondrial distribution reflects the development of oocytes and the post-fertilization of embryos. Some studies showed the quality of oocytes and the rate of embryo formation decreased with the addition of harmful substances to the mitochondrial migration 39,40. However, the mechanisms and causes that affect the mitochondrial distribution in oocytes have not been fully investigated.

GM-CSF had a few beneficial effects on the CG distribution of oocytes from either MFs or SFs. Nevertheless, the combination of pFF and GM-CSF revealed these effects more clearly. When supplemented with pFF in IVM medium, GM-CSF could stimulate the movement of CGs from the cytoplasm to oolema and support the arrangement beneath the oocyte membrane.

Previous studies showed that the distribution of CGs was related to PI3K signaling pathways 41. With the stimulation of GM-CSF, multiple signaling pathways were activated, including the PI3K pathway 6. This may be the cause of the observed enhancement in CG arrangement. However, there are more experiments need to be done to find out the GM-CSF signaling pathways involved in the CG distribution in oocytes.

According to a study by Revelli in 2009, there were 31 proteins found in pFF 42. In addition, many other components have not been completely identified, and their function in the maturation of porcine oocytes is not fully understood. Therefore, the mechanism how GM-CSF and pFF acting on oocyte maturation must be identified before embryologists determine whether using GM-CSF in IVM technique.

Conclusions

GM-CSF did not affect the nuclear maturation and the lipid droplet localization. However, it improved the cumulus expansion in the in vitro maturation of porcine oocytes. Furthermore, it exhibited some benefits in the mitochondrial and cortical granule distribution, especially in combination with pFF in oocytes collected from 3-7 mm follicles. In conclusion, porcine GM-CSF had some positive effects on the porcine oocyte maturation.

Abbreviations

BSA: bovine serum albumin

CG: cortical granule

COC: cumulus-oocyte complex

CSF: colony-stimulating factor

EGF: epidermal growth factor

FF: follicular fluid

FSH: Follicle stimulating hormone

G-CSF: Granulocyte-colony stimulating factor

GM-CSF: Granulocyte Macrophage-colony stimulating factorh

CG: human chorionic gonadotropin

IL: interleukin

IU: international unit

IVM: in vitro maturation

IVMM: in vitro maturation medium

LH: Luteinizing hormone

JAK/STAT: Janus kinase/signal transducers and activators of transcription

MAPK: mitogen-activated protein kinase

MF: medium follicle

PBS: Phosphate-buffered saline

PI3-K: phosphatidylinositol 3-kinase

PMSG: pregnant mare serum gonadotropin

PVA: polyvinyl alcohol

M-CSF: Macrophage colony stimulating factor

PCOS: Polycystic Ovary Syndrome

pFF: porcine follicular fluid

SF: small follicle

TLR: toll-like receptor

TNF: tumor necrosis factor

Competing Interests

The authors report no conflicts of interest in this work.

Authors' Contributions

LTD: designed the experiments, conducted the experiments concerned to COCs from SFs, performed the mitochondrial and cortical granule distribution assays in COCs from MFs and wrote the manuscript. TTTL and CMH: isolated and cultured the COCs from MFs, performed the cumulus expansion, polar body extrusion and lipid droplet localization assays and wrote the manuscript. SNH: analyzed the data, discussed and revised the manuscript. All authors read and approved the final manuscript.

Acknowledgments

The authors give thanks to B.Sc. Quy Xuan Nguyen for sample collection during methods testing; M.Sc. Oanh Thi-Kieu Nguyen and B.Sc. Nhat Chau Truong for assistance in statistical analysis and graph designing.

The study was financially supported by Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University – Ho Chi Minh City, Vietnam.

References

  1. Deshmukh R.S., Ostrup O., Ostrup E., Vejlsted M., Niemann H., Lucas-Hahn A.. DNA methylation in porcine preimplantation embryos developed in vivo and produced by in vitro fertilization, parthenogenetic activation and somatic cell nuclear transfer. Epigenetics. 2011; 6 (2) : 177-87 .
    View Article    PubMed    Google Scholar 
  2. Ito M., Iwata H., Kitagawa M., Kon Y., Kuwayama T., Monji Y.. Effect of follicular fluid collected from various diameter follicles on the progression of nuclear maturation and developmental competence of pig oocytes. Anim Reprod Sci. 2008; 106 (3-4) : 421-30 .
    View Article    PubMed    Google Scholar 
  3. Oberlender G., Murgas L.D., Zangeronimo M.G., da Silva A.C., Menezes T.A., Pontelo T.P., others Role of insulin-like growth factor-I and follicular fluid from ovarian follicles with different diameters on porcine oocyte maturation and fertilization in vitro. Theriogenology. 2013; 80 (4) : 319-27 .
    View Article    PubMed    Google Scholar 
  4. Rahmati M., Petitbarat M., Dubanchet S., Bensussan A., Chaouat G., Ledee N.. Colony Stimulating Factors 1, 2, 3 and early pregnancy steps: from bench to bedside. J Reprod Immunol. 2015; 109 : 1-6 .
    View Article    PubMed    Google Scholar 
  5. Sirotkin A.V., Dukesová J., Makarevich A.V., Kubek A., Bulla J.. Evidence that growth factors IGF-I, IGF-II and EGF can stimulate nuclear maturation of porcine oocytes via intracellular protein kinase A. Reprod Nutr Dev. 2000; 40 (6) : 559-69 .
    View Article    PubMed    Google Scholar 
  6. Martinez-Moczygemba M., Huston D.P.. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol. 2003; 112 (4) : 653-65 .
    View Article    PubMed    Google Scholar 
  7. Hayashida K., Kitamura T., Gorman D.M., Arai K., Yokota T., Miyajima A.. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA. 1990; 87 (24) : 9655-9 .
    View Article    PubMed    Google Scholar 
  8. Robertson S.A.. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev. 2007; 18 (3-4) : 287-98 .
    View Article    PubMed    Google Scholar 
  9. Burgess A.W., Camakaris J., Metcalf D.. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem. 1977; 252 (6) : 1998-2003 .
    PubMed    Google Scholar 
  10. Metcalf D.. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 1986; 67 (2) : 257-67 .
    PubMed    Google Scholar 
  11. Takahashi M., Nikkuni K., Moriyama Y., Shibata A.. GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am J Hematol. 1991; 36 (3) : 213-4 .
    View Article    PubMed    Google Scholar 
  12. Frank J., Engler-Blum G., Rodemann H.P., Müller G.A.. Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol. 1993; 1 (1) : 26-35 .
    PubMed    Google Scholar 
  13. Nishihara T., Ochi M., Sugimoto K., Takahashi H., Yano H., Kumon Y., others Subcutaneous injection containing IL-3 and GM-CSF ameliorates stab wound-induced brain injury in rats. Exp Neurol. 2011; 229 (2) : 507-16 .
    View Article    PubMed    Google Scholar 
  14. Fleetwood A.J., Cook A.D., Hamilton J.A.. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol. 2005; 25 (5) : 405-28 .
    View Article    PubMed    Google Scholar 
  15. Sallerfors B.. Endogenous production and peripheral blood levels of granulocyte-macrophage (GM-) and granulocyte (G-) colony-stimulating factors. Leuk Lymphoma. 1994; 13 (3-4) : 235-47 .
    View Article    PubMed    Google Scholar 
  16. Hamilton J.A.. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008; 8 (7) : 533-44 .
    View Article    PubMed    Google Scholar 
  17. Shannon M.F., Himes S.R., Coles L.S.. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells. J Leukoc Biol. 1995; 57 (5) : 767-73 .
    View Article    PubMed    Google Scholar 
  18. van Nieuwenhuijze A., Koenders M., Roeleveld D., Sleeman M.A., van den Berg W., Wicks I.P.. GM-CSF as a therapeutic target in inflammatory diseases. Mol Immunol. 2013; 56 (4) : 675-82 .
    View Article    PubMed    Google Scholar 
  19. Conti L., Gessani S.. GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology. 2008; 213 (9-10) : 859-70 .
    View Article    PubMed    Google Scholar 
  20. Barreda D.R., Hanington P.C., Belosevic M.. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 2004; 28 (5) : 509-54 .
    View Article    PubMed    Google Scholar 
  21. Robertson S.A., Sjöblom C., Jasper M.J., Norman R.J., Seamark R.F.. Granulocyte-macrophage colony-stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos. Biol Reprod. 2001; 64 (4) : 1206-15 .
    View Article    PubMed    Google Scholar 
  22. Peralta O.A., Bucher D., Angulo C., Castro M.A., Ratto M.H., Concha I.. Tissue localization of GM-CSF receptor in bovine ovarian follicles and its role on glucose uptake by mural granulosa cells. Anim Reprod Sci. 2016; 170 : 157-69 .
    View Article    PubMed    Google Scholar 
  23. Sjöblom C., Wikland M., Robertson S.A.. Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod. 2002; 67 (6) : 1817-23 .
    View Article    PubMed    Google Scholar 
  24. Calhoun D.A., Donnelly Jr, W.H., Du Y., Dame J.B., Li Y., Christensen R.D.. Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr Res. 1999; 46 (3) : 333-8 .
    View Article    PubMed    Google Scholar 
  25. Hammadeh M.E., Fischer-Hammadeh C., Georg T., Rosenbaum P., Schmidt W.. Comparison between cytokine concentration in follicular fluid of poor and high responder patients and their influence of ICSI-outcome. Am J Reprod Immunol. 2003; 50 (2) : 131-6 .
    View Article    PubMed    Google Scholar 
  26. Li R., Murphy C.N., Spate L., Wax D., Isom C., Rieke A., others Production of piglets after cryopreservation of embryos using a centrifugation-based method for delipation without micromanipulation. Biol Reprod. 2009; 80 (3) : 563-71 .
    View Article    PubMed    Google Scholar 
  27. Gil M.A., Maside C., Cuello C., Parrilla I., Vazquez J.M., Roca J., others Effects of Hoechst 33342 staining and ultraviolet irradiation on mitochondrial distribution and DNA copy number in porcine oocytes and preimplantation embryos. Mol Reprod Dev. 2012; 79 (9) : 651-63 .
    View Article    PubMed    Google Scholar 
  28. Lin T., Diao Y.F., Kang J.W., Lee J.E., Kim D.K., Jin D.I.. Chromosomes in the porcine first polar body possess competence of second meiotic division within enucleated MII stage oocytes. PLoS One. 2013; 8 (12) : e82766 .
    View Article    PubMed    Google Scholar 
  29. Hiraga K., Hoshino Y., Tanemura K., Sato E.. Selection of in vitro-matured porcine oocytes based on localization patterns of lipid droplets to evaluate developmental competence. J Reprod Dev. 2013; 59 (4) : 405-8 .
    View Article    PubMed    Google Scholar 
  30. Pawlak Piotr, Chabowska Agnieszka, Malyszka Natalia, Lechniak Dorota. Mitochondria and mitochondrial DNA in porcine oocytes and cumulus cells—a search for developmental competence marker. Mitochondrion. 2016; 27 : 48-55 .
  31. Lin Tao, Diao Yun Fei, Choi Hwa Sik, Oqani Reza K, Kang Jung Won, Lee Jae Eun, Jin Dong Il. Procedure used for denuding pig oocytes influences oocyte damage, and development of in vitro and nuclear transfer embryos. Animal reproduction science. 2015; 152 : 65-76 .
  32. Peralta O.A., Bucher D., Fernandez A., Berland M., Strobel P., Ramirez A.. Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances cumulus cell expansion in bovine oocytes. Reprod Biol Endocrinol. 2013; 11 (1) : 55 .
    View Article    PubMed    Google Scholar 
  33. Nagyová E., Procházka R., Vanderhyden B.C.. Oocytectomy does not influence synthesis of hyaluronic acid by pig cumulus cells: retention of hyaluronic acid after insulin-like growth factor-I treatment in serum-free medium. Biol Reprod. 1999; 61 (3) : 569-74 .
    View Article    PubMed    Google Scholar 
  34. Conti M., Hsieh M., Park J.Y., Su Y.Q.. Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol. 2006; 20 (4) : 715-23 .
    View Article    PubMed    Google Scholar 
  35. Nemcová L., Nagyová E., Petlach M., Tománek M., Procházka R.. Molecular mechanisms of insulin-like growth factor 1 promoted synthesis and retention of hyaluronic acid in porcine oocyte-cumulus complexes. Biol Reprod. 2007; 76 (6) : 1016-24 .
    View Article    PubMed    Google Scholar 
  36. Hill A.D., Naama H.A., Calvano S.E., Daly J.M.. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leukoc Biol. 1995; 58 (6) : 634-42 .
    View Article    PubMed    Google Scholar 
  37. Uhm S.J., Gupta M.K., Yang J.H., Chung H.J., Min T.S., Lee H.T.. Epidermal growth factor can be used in lieu of follicle-stimulating hormone for nuclear maturation of porcine oocytes in vitro. Theriogenology. 2010; 73 (8) : 1024-36 .
    View Article    PubMed    Google Scholar 
  38. Mito T., Yoshioka K., Noguchi M., Yamashita S., Hoshi H.. Recombinant human follicle-stimulating hormone and transforming growth factor-alpha enhance in vitro maturation of porcine oocytes. Mol Reprod Dev. 2013; 80 (7) : 549-60 .
    View Article    PubMed    Google Scholar 
  39. Magata F., Shimizu T.. Effect of lipopolysaccharide on developmental competence of oocytes. Reprod Toxicol. 2017; 71 : 1-7 .
    View Article    PubMed    Google Scholar 
  40. Stojkovic M., Machado S.A., Stojkovic P., Zakhartchenko V., Hutzler P., Gonçalves P.B., others Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol Reprod. 2001; 64 (3) : 904-9 .
    View Article    PubMed    Google Scholar 
  41. Tumova L., Romar R., Petr J., Sedmikova M.. The effect of protein kinase C activator and nitric oxide donor on oocyte activation and cortical granule exocytosis in porcine eggs. Animal : an international journal of animal bioscience. 2013; 7 (2) : 279-286 .
    View Article    Google Scholar 
  42. Revelli A., Delle Piane L., Casano S., Molinari E., Massobrio M., Rinaudo P.. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. 2009; 7 (1) : 40 .
    View Article    PubMed    Google Scholar 

Comments